Craig Collard - Sep 13, 2021 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC. (OPNT)

Role
Director
Signature
/s/ Craig Collard
Stock symbol
OPNT
Transactions as of
Sep 13, 2021
Transactions value $
$67,062
Form type
4
Date filed
9/15/2021, 04:01 PM
Previous filing
Sep 13, 2021
Next filing
Nov 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Purchase $45.3K +2.5K +18.41% $18.13 16.1K Sep 13, 2021 Direct F1
transaction OPNT Common Stock Award $9.09K +506 +3.15% $17.96 16.6K Sep 13, 2021 Direct F2
transaction OPNT Common Stock Award $12.6K +700 +4.22% $18.07 17.3K Sep 13, 2021 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $18.05 to $18.16. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $17.94 to $17.97. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $18.02 to $18.15. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.